Generic Otc Meds LLC is categorized under Medical Apparatus and Supplies in Albuquerque, NM and active since 2006.
Generic Otc Meds LLC was established in 2006, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Apparatus and Supplies business, which does work in the B2C market, and is classified as a Medical Apparatus and Supplies, under code number 446199 by the NAICS.
If you are seeking more information, feel free to contact Felix Mauro Torres at the company’s single location by writing to 1601 Columbia Drive Se, Albuquerque, New Mexico NM 87106 or by phoning (505) 247-0862. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Generic Otc Meds LLC |
Contact Person: | Felix Mauro Torres |
Address: | 1601 Columbia Drive Se, Albuquerque, New Mexico 87106 |
Phone Number: | (505) 247-0862 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2006 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Medical Apparatus and Supplies |
SIC Code: | 5999 |
NAICS Code: | 446199 |
Share This Business: |
Generic Otc Meds LLC was started in 2006 to provide professional Medical Apparatus and Supplies under the SIC code 5999 and NAICS code 446199. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Felix Mauro Torres for inquiries that concern Generic Otc Meds LLC by calling the company number (505) 247-0862, as your correspondence is most welcome. Additionally, the physical location of the single location of Generic Otc Meds LLC can be found at the coordinates 35.064893,-106.616546 as well as the street address 1601 Columbia Drive Se in Albuquerque, New Mexico 87106.
For its online presence, you may visit Generic Otc Meds LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.